Research News

May 23, 2011
Can Text Messaging Improve Medication Adherence?

Text messaging and adolescents don’t always mix well, but researchers at National Jewish Health hope text messages can spur teenagers to take their asthma medications more reliably.

May 13, 2011
National Jewish Health Faculty Present Latest Findings at American Thoracic Society 2011

Highlighted presentations by National Jewish Health faculty at the 2011 American Thoracic Society International Conference

April 20, 2011
Genetic Discovery Offers New Hope in Fight Against Deadly Pulmonary Fibrosis

A team led by researchers at National Jewish Health has discovered a new genetic variation that increases the risk of developing pulmonary fibrosis by 7 to 22 times.

April 14, 2011
Children Restricting Diets Based on Incomplete Allergy Information

Many children, especially those with eczema, are unnecessarily avoiding foods based on incomplete information about potential food-allergies, according to researchers at National Jewish Health. The food avoidance poses a nutritional risk for these children.

    March 16, 2011
    Omalizumab Relieves Seasonal Asthma Attacks in Youth
    A drug that targets the antibody immunoglobulin E (IgE), a key player in asthma, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among young people living in inner city environments.

    March 1, 2011
    Treating Peanut Allergy Through a Patch
    The peanut patch would seek to desensitize allergic patients by exposing them to increasing amounts of peanut protein.

    January 31, 2011
    Researchers Discover Signaling Pathway Crucial to Acute Lung Injury
    The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets for this deadly disease.

    January 25, 2011
    New Method Attacks Bacterial Infections on Contact Lenses
    Researchers have discovered a new method to fight bacterial infections associated with contact lenses. The method may also have applications for bacterial infections associated with severe burns and cystic fibrosis.

    January 21, 2011
    Power of Personal Contact
    A recent study points to the power of live telephone counseling to help people quit smoking

    January 18, 2011
    Patent  for Method to Dampen Immune Response
    B cell receptorNational Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating antigen receptors on their surfaces. The discovery holds promise for treatment of cancer, autoimmune diseases, transplant rejection.

    January 12, 2011
    Lipid Broadens Anti-inflammatory Portfolio
    A naturally occurring lipid has broader anti-inflammatory effects in the lungs than previously shown.

    January 06, 2011
    National Jewish Health Secures Six Patents in 2010
    This number represents one of the best years on record for National Jewish, despite a severe decrease in the patent allowance rate by the USPTO in the last 10 years.

    November 04, 2010
    Many Children Restricting Diets Unnecessarily Based on Incomplete Allergy Information
    Many children, especially those with eczema, are unnecessarily avoiding foods based on incomplete information about potential food-allergies, according to researchers at National Jewish Health. The food avoidance poses a nutritional risk for these children.

    November 01, 2010
    National Jewish Health Receives Patent for Diagnostic Method of Autoimmune Chronic Urticaria

    National Jewish Health has received a US patent for a method of detecting autoimmune chronic urticaria, which will help assure many patients that dramatic changes in lifestyle are not needed to treat the condition.

    October 04, 2010
    Food Allergies Raise Risk of Asthma Attacks

    Food allergies are more common among people with asthma and may contribute to asthma attacks, according to one of the most comprehensive surveys of food allergies ever undertaken.

    September 27, 2010
    National Jewish Health Receives Patent for Liposome-Based Vaccine

    National Jewish Health has received a US patent for a new kind of vaccine, which uses a small lipid bubble to deliver an antigen and DNA adjuvant.

    September 20, 2010
    Study Suggests Alternate Therapy for Adults with Poorly Controlled Asthma

    Results of a clinical trial suggest tiotropium is an effective add-on therapy for asthma that is poorly controlled by inhaled steroids alone.

    August 12, 2010
    Sildenafil Shows Small Benefit in Patients with Idiopathic Pulmonary Fibrosis

    Sildenafil failed to significantly increase exercise capacity, but did improve arterial oxygenation, shortness of breath and quality of life in patients with advanced idiopathic pulmonary fibrosis (IPF), in the first randomized trial of the medication for IPF.

    August 03, 2010
    Lung Genomics Research Consortium Launches Website

    The Lung Genomics Research Consortium (LGRC) today launched its public awareness website, which highlights the Consortium’s recently established research initiative to study lung disease, including chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD), at the genetic and genomic levels.

    July 22, 2010
    NIH Awards National Jewish Health $31 Million to Lead Study of Infections Associated with Eczema

    The NIH has awarded a five-year $31 million contract to National Jewish Health to lead a study of skin infections associated with atopic dermatitis, especially antibiotic-resistant staphylococcus aureus or MRSA.

    July 14, 2010
    NIH Expands Food Allergy Program

    CoFAR will continue to foster new approaches to prevent and treat food allergies and also expand in scope to include research on the genetic causes underlying food allergy and studies of food allergy-associated eosinophilic gastrointestinal diseases.

    July 07, 2010
    Genetic Ancestry Data Improve Diagnosis in Asthma and Lung Disease

    In the largest study of its kind to date, which pooled data on more than 3,000 patients, researchers at National Jewish Health and several other institutions found that patients’ precise genetic background told far more about their potential lung function – and therefore any damage that has occurred – than the self-identified racial profile commonly used in such tests.

    July 05, 2010
    Researchers Discover Trigger to Early, Effective Antibody Response

    Researchers at National Jewish Health have discovered a trigger that induces B cells to produce effective and long-lived antibodies early in the immune response.

    June 15, 2010
    Insulin Peptide May Point to Solution for Type 1 Diabetes

    Researchers at National Jewish Health have identified the precise protein fragment that can trigger diabetes in mice. The finding supports an emerging theory about the origins of autoimmunity, and may lead to new diagnostic and therapeutic strategies in humans.

    May 20, 2010
    Longer Survival Changing the Face of Cystic Fibrosis

    Cystic fibrosis has been transformed in recent decades from a uniformly fatal childhood disease to a condition with middle-aged and older patients. A comprehensive analysis of cystic fibrosis patients over 40 by researchers at National Jewish Health highlights patients who have survived with the disease for decades and an emerging population of patients diagnosed as adults.

    May 17, 2010
    Gregory Downey, MD, Honored for Scientific Accomplishments
    Gregory Downey, MD, of National Jewish Health, received the 2010 Recognition Award for Scientific Accomplishments at the American Thoracic Society’s (ATS) International Conference on Monday, May 17, 2010.

    April 30, 2010
    Discovery Prompts New Theory on Cause of Diabetes, Other Autoimmune Diseases

    Researchers at National Jewish Health and the University of Colorado Denver propose that the unusual and rare presentation of protein fragments (peptides) to the immune system allows autoreactive T cells to escape the thymus and trigger autoimmune disease.

    April 15, 2010
    Low Vitamin D Levels Associated with More Asthma Symptoms and Medication Use

    Low levels of vitamin D are associated with lower lung function and greater medication use in children with asthma, according to researchers at National Jewish Health.

    March 24, 2010
    National Jewish Researchers Discover Fundamental Step in Immune-System Development

    Researchers at National Jewish Health have discovered a fundamental step in the development of the immune system, one that allows B cells to mature and fight disease by producing effective antibodies.

    March 17, 2010
    National Jewish Health Researcher Pippa Marrack, PhD, Named to Colorado Women's Hall of Fame
    For more than 30 years, Dr. Marrack's research has focused primarily on the T cell, an immune-system cell that recognizes foreign substances in the body and orchestrates the adaptive immune response.

    March 09, 2010
    National Jewish Health Receives Grant to Learn How Families Cope with Food Allergy

    March 9, 2010 How Do Families Cope with Food Allergies? Mary Klinnert, PhD, Associate Professor of Pediatrics at National Jewish Health, has received a $450,000 grant from the NIH to study how different families adapt to life with food allergies, and to discover what helps the best-adapted families cope well.

    March 02, 2010
    Long-Acting Beta-Agonists Shown to be Most Effective Step-Up Therapy for Children with Poorly Controlled Asthma

    For children whose asthma is not well controlled and on low doses of inhaled corticosteroids, a long-acting beta-agonist (LABA) may be the most effective of three possible step-up treatments.

    March 02, 2010
    National Jewish Faculty Present Research Findings at American Academy of Allergy Asthma & Immunology

    Dozens of National Jewish Health faculty presented their latest research findings at the annual meeting of the American Academy of Allergy Asthma & Immunology in New Orleans Feb 27-March 2, 2010. Below are several noteworthy presentations.

    February 15, 2010
    New Strategy Produces Promising Advance in Cancer Vaccines

    Researchers at National Jewish Health and the University of Colorado Denver used a new strategy to develop cancer vaccines that were remarkably effective in mice.

    February 15, 2010
    Researchers Discover How Virulent Bacteria Sabotage Immune Response Against Them

    Researchers at National Jewish Health have discovered how the virulent food-borne bacteria Listeria monocytogenes induces infected immune cells to sabotage their own defensive response. The studies offer insight into host-pathogen interactions and suggest potential therapeutic targets for food poisoning, tuberculosis and autoimmune diseases.

    January 28, 2010
    Low Vitamin D Associated with Worse Asthma
    Low levels of vitamin D in asthma patients are associated with reduced lung function and less response to steroid medications, according to researchers at National Jewish Health.

    January 25, 2010
    National Jewish Health Awarded $1 Million to Develop Cell Transplants for Damaged Lungs

    National Jewish Health researchers will evaluate cell transplantation as a novel therapy for acute lung injury.

    Last Updated: 1/2016

    News Archive
    Browse by Year

    Search All


    Media Contacts


    In the Newsroom, you can find National Jewish Health press releases, newsletters, annual reports and media contacts. Learn more.


    Sign Up for e-Newsletters

    Enter your email address to receive health tips, recent research findings and news about National Jewish Health.